Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0329 | ||||
Gene Name | SLC38A2 | ||||
Protein Name | Sodium-coupled neutral amino acid transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | ATA2; Amino acid transporter A2; KIAA1382; PRO1068; Protein 40-9-1; SAT2; SLC38A2; SNAT2; Solute carrier family 38 member 2; System A amino acid transporter 2; System A transporter 1; System N amino acid transporter 2 | ||||
DT Family | Amino Acid/Auxin Permease (AAAP) Family ; | ||||
Tissue Specificity | Ubiquitously expressed. Widely expressed inthe central nervous system with higher concentrations in caudalregions. Expressed by glutamatergic and GABAergic neurons togetherwith astrocytes and other non-neuronal cells in the cerebralcortex (at protein level). | ||||
Function | This sodium-dependent amino acid transporter mediates the saturable, pH-sensitive and electrogenic cotransport of neutral amino acids and sodium ions with a stoichiometry of 1:1. May function in the transport of amino acids at the blood-brain barrier and in the supply of maternal nutrients to the fetus through the placenta. | ||||
Disease(s) | Short bowel syndrome [ICD-11: KB89.1] | ||||
Endogenous Substrate(s) | Amino acids; Sodium ion | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 2 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
L-alanine
|
Approved | Drug Info | Glioma | 2A00.0 | [1] |
L-glutamine
|
Approved | Drug Info | Short bowel syndrome | KB89.1 | [1] |
References | |||||
1 | Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons. J Biol Chem. 2011 Jun 10;286(23):20500-11. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.